Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: J Surg Oncol. 2021 Apr 18;124(3):271–281. doi: 10.1002/jso.26500

Table 4:

Concurrence between the surgeons’ confidence in identifying parathyroid and PTeye™ output. (PG, parathyroid gland).

Surgeon’s
confidence in tissue
being PG
In-situ
(Final
surgeon’s
opinion
for
validation)
Excised
(FSA/
Permanent
histology
for
validation)
Target
tissues
tested
(n)
Device
Positive:
Detection
ratio >1.2
(n)
True
Positive:
Detection
ratio >1.2
(n, %)
False
Positive:
Detection
ratio >1.2
(n, %)
Device
Negative:
Detection
ratio <1.2
(n)
True
Negative:
Detection
ratio <1.2
(n, %)
False
Negative:
Detection
ratio <1.2
(n, %)
19 patients – initial set
High (>75%) 33 21 54 54 52 (96.3) 2 (3.7) 0 0 (0) 0 (0)
Medium (50-75%) 1 1 2 2 2 (100) 0 (0) 0 0 (0) 0 (0)
Low (<50%) 8 6 14 3 2 (66.7) 1 (33.3) 11 11 (100) 0 (0)
Total 42 28 70 59 56 (94.9) 3 (5.1%) 11 11 (100) 0 (0)
64 patients – second set
High (>75%) 108 64 172 172 169 (98.3) 3 (1.7) 0 0 (0) 0 (0)
Medium (50-75%) 25 0 25 23 22 (95.7) 1 (4.3) 2 2 (100) 0 (0)
Low (<50%) 62 7 69 18 6 (33.3) 12 (66.7) 51 51 (100) 0 (0)
Total 195 71 266 213 197 (92.5) 16 (7.5) 53 53 (100) 0 (0)
83 patients – overall
High (>75%) 141 85 226 226 221 (97.8) 5 (2.2) 0 0 (0) 0 (0)
Medium (50-75%) 26 1 27 25 24 (96) 1 (4) 2 2 (100) 0 (0)
Low (<50%) 70 13 83 21 8 (38.1) 13 (61.9) 62 62 (100) 0 (0)
Total 237 99 336 272 253 (93.0) 19 (7.0) 64 64 (100) 0 (0)

Number of true positive, false positive, true negative and false negative (see Table 2) was determined by surgeon’s judgement (for in-situ tissues) or histology (for excised tissues).